INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

ACLXArcellx, Inc.

CIK 0001786205

EDGAR filingsOpen in network
Disclosed transactions25
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

ACLX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MK
Myers KristinDirector
ACLXArcellx, Inc.
Disposition to issuer
D—
16.8K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Myers KristinDirector · Apr 28, 2026
  • ← Insider ofevidence
    Gilson MichelleCHIEF FINANCIAL OFFICER · Apr 28, 2026
  • ← Insider ofevidence
    Heery ChristopherCHIEF MEDICAL OFFICER · Apr 28, 2026
9
MK
Myers KristinDirector
ACLXArcellx, Inc.
Disposition to issuer
D
—
1,784 sh
Apr 28, 2026
Apr 28, 2026
traded Apr 28, 2026
+0d
SEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Tender of shares
U—
67.0K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Tender of shares
U—
5,000 sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
40.2K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
32.5K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
70.8K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
94.6K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
20.5K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
61.6K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
88.5K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Grant or award
A—
59.0K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
GM
Gilson MichelleCHIEF FINANCIAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
59.0K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Tender of shares
U—
23.7K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
10.9K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
43.6K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
132.4K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
40.0K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
76.2K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
60.1K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
13.0K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
39.2K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
67.7K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Grant or award
A—
45.1K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

9
HC
Heery ChristopherCHIEF MEDICAL OFFICER
ACLXArcellx, Inc.
Disposition to issuer
D—
45.1K sh
Apr 28, 2026Apr 28, 2026
traded Apr 28, 2026
+0dSEC FORM 4

Evidence

Source error

Price history for ACLX is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.